Literature DB >> 23652445

Obesity and heart failure as a mediator of the cerebrorenal interaction.

Ankur Jindal1, Adam Whaley-Connell, James R Sowers.   

Abstract

The obesity epidemic is contributing substantially to the burden of cardiovascular disease including heart disease and congestive heart failure, in the United States and the rest of the world. Overnutrition as a driver of obesity, promotes alterations in fatty acid, lipid, and glucose metabolism that influence myocardial function and progression of heart failure from diastolic to systolic failure. The association of progressive heart failure and progressive chronic kidney disease is well documented and often referred to as the cardiorenal syndrome, as well as a prognosticator for cerebrovascular disease (e.g. stroke). Whether the relationship between obesity, heart disease/failure and risk for chronic kidney disease and stroke is direct or a confluence of risk factors is poorly understood.
Copyright © 2013 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23652445      PMCID: PMC4315619          DOI: 10.1159/000346718

Source DB:  PubMed          Journal:  Contrib Nephrol        ISSN: 0302-5144            Impact factor:   1.580


  34 in total

1.  Impact of body mass index and waist circumference on the cardiovascular risk and all-cause death in a general population: data from the PAMELA study.

Authors:  M Bombelli; R Facchetti; D Fodri; G Brambilla; R Sega; G Grassi; G Mancia
Journal:  Nutr Metab Cardiovasc Dis       Date:  2012-05-26       Impact factor: 4.222

Review 2.  Association of overweight with increased risk of coronary heart disease partly independent of blood pressure and cholesterol levels: a meta-analysis of 21 cohort studies including more than 300 000 persons.

Authors:  Rik P Bogers; Wanda J E Bemelmans; Rudolf T Hoogenveen; Hendriek C Boshuizen; Mark Woodward; Paul Knekt; Rob M van Dam; Frank B Hu; Tommy L S Visscher; Alessandro Menotti; Roland J Thorpe; Konrad Jamrozik; Susanna Calling; Bjørn Heine Strand; Martin J Shipley
Journal:  Arch Intern Med       Date:  2007-09-10

Review 3.  Excess body weight and incidence of stroke: meta-analysis of prospective studies with 2 million participants.

Authors:  Pasquale Strazzullo; Lanfranco D'Elia; Giulia Cairella; Francesca Garbagnati; Francesco P Cappuccio; Luca Scalfi
Journal:  Stroke       Date:  2010-03-18       Impact factor: 7.914

4.  Cigarette smoking as a risk factor for stroke. The Framingham Study.

Authors:  P A Wolf; R B D'Agostino; W B Kannel; R Bonita; A J Belanger
Journal:  JAMA       Date:  1988-02-19       Impact factor: 56.272

Review 5.  Lipotoxicity in type 2 diabetic cardiomyopathy.

Authors:  Tineke van de Weijer; Vera B Schrauwen-Hinderling; Patrick Schrauwen
Journal:  Cardiovasc Res       Date:  2011-07-29       Impact factor: 10.787

6.  Heart disease and stroke statistics--2006 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee.

Authors:  Thomas Thom; Nancy Haase; Wayne Rosamond; Virginia J Howard; John Rumsfeld; Teri Manolio; Zhi-Jie Zheng; Katherine Flegal; Christopher O'Donnell; Steven Kittner; Donald Lloyd-Jones; David C Goff; Yuling Hong; Robert Adams; Gary Friday; Karen Furie; Philip Gorelick; Brett Kissela; John Marler; James Meigs; Veronique Roger; Stephen Sidney; Paul Sorlie; Julia Steinberger; Sylvia Wasserthiel-Smoller; Matthew Wilson; Philip Wolf
Journal:  Circulation       Date:  2006-01-11       Impact factor: 29.690

7.  Chronic kidney disease, anemia, and incident stroke in a middle-aged, community-based population: the ARIC Study.

Authors:  Jerome L Abramson; Claudine T Jurkovitz; Viola Vaccarino; William S Weintraub; William McClellan
Journal:  Kidney Int       Date:  2003-08       Impact factor: 10.612

8.  Predictors of severe stroke: influence of preexisting dementia and cardiac disorders.

Authors:  Peter Appelros; Ingegerd Nydevik; Ake Seiger; Andreas Terént
Journal:  Stroke       Date:  2002-10       Impact factor: 7.914

9.  Kidney dysfunction as a risk factor for first symptomatic stroke events in a general Japanese population--the Ohasama study.

Authors:  Masaaki Nakayama; Hirohito Metoki; Hiroyuki Terawaki; Takayoshi Ohkubo; Masahiro Kikuya; Toshinobu Sato; Keisuke Nakayama; Kei Asayama; Ryusuke Inoue; Junichiro Hashimoto; Kazuhito Totsune; Haruhisa Hoshi; Sadayoshi Ito; Yutaka Imai
Journal:  Nephrol Dial Transplant       Date:  2007-03-29       Impact factor: 5.992

10.  Substrate-specific derangements in mitochondrial metabolism and redox balance in the atrium of the type 2 diabetic human heart.

Authors:  Ethan J Anderson; Alan P Kypson; Evelio Rodriguez; Curtis A Anderson; Eric J Lehr; P Darrell Neufer
Journal:  J Am Coll Cardiol       Date:  2009-11-10       Impact factor: 24.094

View more
  3 in total

Review 1.  Estrogen and mitochondria function in cardiorenal metabolic syndrome.

Authors:  Guanghong Jia; Annayya R Aroor; James R Sowers
Journal:  Prog Mol Biol Transl Sci       Date:  2014       Impact factor: 3.622

Review 2.  Role of mineralocorticoid receptor activation in cardiac diastolic dysfunction.

Authors:  Guanghong Jia; Yan Jia; James R Sowers
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2016-10-29       Impact factor: 5.187

Review 3.  Mitochondrial functional impairment in response to environmental toxins in the cardiorenal metabolic syndrome.

Authors:  Guanghong Jia; Annayya R Aroor; Luis A Martinez-Lemus; James R Sowers
Journal:  Arch Toxicol       Date:  2015-01-06       Impact factor: 5.153

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.